The first Brooklyn ImmunoTherapeutics trade was made in Q1 2021.
Since then Ken Griffin bought shares four more times and sold shares on three occasions. The investor completely sold their stake between Q3 2022 and Q4 2022.
Avg closing price
Price range
Sold -2.53 Thousand shares
Q4 2022
Avg closing price
$4.46
Price range
$4.00
-
$5.05
Sold 75.6% shares (-7.81 Thousand shares)
Q3 2022
Avg closing price
$9.19
Price range
$4.39
-
$14.26
Increased shares by 21.6% (+1.84 Thousand shares)
Q2 2022
Avg closing price
$19.14
Price range
$9.53
-
$40.60
Increased shares by 44.8% (+2.63 Thousand shares)
Q1 2022
Avg closing price
$50.59
Price range
$35.20
-
$96.80
Increased shares by 668.8% (+5.11 Thousand shares)
Q4 2021